pravastatin
pravastatin: sourced relationships with 1 company · 2 clinical trials tracked · 1 FDA decision.
pravastatin evidence translation
What we can confirm
1 FDA record · 2 tracked trials
What it means
What to watch
Prepared research question
How could pravastatin → RDY affect its developer, and what evidence supports the link?
Traceable citations · Unknowns marked
See linked entities and source evidence2 indications · 0 study sponsors
Related indications
Study sponsors
No additional listed-company sponsor is linked.
Dated Pipeline Records (1)
| Company | Dated record stage |
|---|---|
| DR REDDYS LABORATORIES LTD (RDY) Reported 2006-10-23 · Current development: unknownSource | Approved |
Clinical Trial Registry Records (2)
A Phase 1 Clinical Trial in Healthy Participants to Evaluate the Safety, Tolerability, and Pharmacokinetics of Single and Multiple Ascending Doses of TERN-701, the Effects of Food, Acid-Reducing Agents, and Drug-Drug Interactions, and the Relative Bioavailability of New Tablet Formulations of TERN-701
Primary endpoint: Number of Participants Who Experience a Treatment Emergent Adverse Event (AE)
Randomised Comparative Study of the Efficacy and Safety of Rosuvastatin and Pravastatin in Dyslipidemic Patients Treated With Antiretroviral Agents. Anrs 126
Primary endpoint: Compare the change in LDL cholesterol between D0 and D45, in patients receiving rosuvastatin (10 mg/day) or pravastatin (40 mg/day) and treated by antiretroviral agents including a boosted protease inhibitor on D45.
Frequently asked questions
Which companies have sourced relationships with pravastatin?
pravastatin has dated SEC/FDA relationship records for DR REDDYS LABORATORIES LTD.
How many clinical trials involve pravastatin?
BioSniper tracks 2 clinical trials involving pravastatin.
What is pravastatin's latest FDA decision?
The most recent tracked FDA decision for pravastatin is Approval, dated October 23, 2006.